MENU
PRME
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Prime Medicine (PRME) Ownership - Who owns Prime Medicine?

Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression... Show more

Profile

Industry
N/A
Address
60 First Street
Phone
+1 617 465-0013
Employees
146
Web
https://www.primemedicine.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
534.63M
P/E Ratio
N/A
Total Cash
135.5M
Projected Growth
N/A
Total Debt
114.51M
Revenue
4.03M
Risk (Beta)
3.12
Dividend Yield
N/A
Total Cash/Share
0.75
Total Debt/Equity
N/A
Revenue/Share
0.03 USD as % of share price
View a ticker or compare two or three
PRME
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
60 First Street
Phone
+1 617 465-0013
Employees
146
Web
https://www.primemedicine.com